The Big Heart Disease Lie

Instant Treatments for Heart Disease

Get Instant Access

1. Agostoni, P., Marenzi, G., Lauri, G., Perego, G., Schianni, M., Sganzerla, P., and Guazzi, M. D. (1994). Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result. Am. J. Med. 96, 191-199.

2. Barr, C. S., Lang, C. C., Hanson,J., Arnott, M., Kennedy, N., and Struthers, A. D. (1995). Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am. J. Cardiol. 76,1259-1265.

3. Bourland, W. A., Day, D. K, and Williamson, H. E. (1977). The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J. Pharmacol. Exp. Ther. 202, 221-229.

4. Brater, D. C., Kaojaren, S., and Chennavasin, P. (1983). Pharmacodynamics of the diuretic effects of aminophylline and acetazolamide alone and combined with furosemide in normal subjects. J. Pharmacol. Exp. Ther. 227, 92-97.

5. Channer, K. S., McLean, K. A., Lawson-Matthew, P., and Richardson, M. (1994). Combination diuretic treatment in severe heart failure: A randomised controlled trial. Br. Heart ]. 71, 146-150.

6. Chemtob, S., Doray, J.-L., Laudignon, N., Papageorgiou, A., Varma, D. R., and Aranda, J. V. (1989). Alternating sequential dosing with furosemide and ethacrynic acid in drug tolerance in the newborn. Am. J. Dis. Child. 143, 850-854.

7. Chen, Z., F., Vaughn, D. A., Beaumont, K, and Fanestil, D. D. (1990). Effects of diuretic treatment and of dietary sodium on renal binding of 3H-metolazone. ]. Am. Soc. Nephrol. 1,91-98.

8. Curran, K. A., Hebert, M. J., Cain, B. D., and Wingo, C. S. (1992). Evidence for the presence of a K-dependent acidifying adenosine triphosphatase in the rabbit renal medulla. Kidney Int. 42, 1093-1098.

9. Dikshit, K., Vyden, J. K., Forrester, J. S„ Chatterjee, K., Prakash, R., and Swan H.J. C. (1973). Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N. Engl.J. Med. 288, 1087-1090.

10. Ellison, D. H. (1991). The physiologic basis of diuretic synergism: Its role in treating diuretic resistance. Ann. Int. Med. 114, 886-894.

11. Ellison, D. H., Velazquez, H., and Wright, F. S. (1987). Thiazide sensitive sodium chloride cotransport in the early distal tubule. Am. J. Physiol. 253, F546-F554.

12. Ellison, D. H., Velazquez, H., and Wright, F. S. (1989). Adaptation of the distal convoluted tubule of the rat: Structural and functional effects of dietary salt intake and chronic diuretic infusion. J. Clin. Invest. 83, 113-126.

13. Epstein, M., Lepp, B. A., Hoffman, D. S., and Levinson, R. (1977). Potentiation of furosemide by metolazone in refractory edema. Curr. Ther. Res. 21, 656-667.

14. Fliser, D., Schröter, M., Neubeck, M., and Ritz, E. (1994). Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney int. 46, 482-488.

15. Francis, G. S., Siegel, R. M., Goldsmith, S. R., Olivari, M. T„ Levine, B., and Cohn, J. N. (1985). Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann. Intern. Med. 103,1-6.

16. Garg, L. C., and Narang, N. (1987). Effects of hydrochlorothiazide on Na-K-ATPase activity along the rat nephron. Kidney Int. 31, 918-922.

17. Garin, E. H. (1987). A comparison of combinations of diuretics in nephrotic edema. AJDC?? 141,769-771.

18. Gerlag, P. G. G., and Van Meijel, J. J. M. (1988). High-dose furosemide in the treatment of refractory congestive heart failure. Arch. Intern. Med. 148, 286-291.

19. Goldsmith, S. R., Francis, G., and Cohn, J. N. (1989). Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure. Am. J. Cardiol. 64, 1382-1385.

20. lnoue, M., Okajima, K., Itoh, K., Ando, Y., Watanabe, N., Yasaka,T., Nagase, S., andMorino, Y. (1987). Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int. 32,198-203.

21. Johnston, G. D., Nicholls, D. P., and Leahey, W. J. (1984). The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects. Br. J. Clin. Pharmacol. 18,75-81.

22. Lahav, M., Regev, A., Ra'anani, P., and Thodor, E. (1992). Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 102,725-731.

23. Loon, N. R., Wilcox, C. S., and Unwin, R. J. (1989). Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 36, 682—689.

24. Loon, N. R., Wilcox, C. S., and Unwin, R. J. (1989). Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 36, 682-689.

25. Magovern, J. A. and Magovern, G. J., Jr. (1990). Diuresis in hemodynamically compromised patients: Continuous furosemide infusion. Ann. Thorac. Surg. 50, 482—484.

26. Marone, C., Muggli, F., Lahn, W., and Frey, F. J. (1985). Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. Eur. J. Clin. Invest. 15, 253-257.

27. Martin, S. J. and Danziger, L. H. (1994). Continuous infusion of loop diuretics in the critically ill: A Review of the literature. Crit. Care Med. 22, 1323-1329.

28. Miller, P. D., and Berns, A. S. (1977). Acute metabolic alkalosis perpetuating hypercarbia: a role for acedazolamide in chronic obstructive pulmonary disease. J. Am. Med. Assoc. 238, 2400-2401.

29. Morsing, P., Velazquez, H., Wright, F. S., and Ellison D. H. (1991). Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion. Am. J. Physiol. 261, F137-F143.

30. Mukherjee, S. K., Katz, M. A., Michael, U. F., and Ogden, D. A. (1981). Mechanisms of hemodynamic actions of furosemide: Differentiation of vascular and renal effects on blood pressure in functionally anephric hypertensive patients. Am. Heart J. 101, 313-318.

31. Nierenberg, D. W. (1980). Furosemide and ethacrynic acid in acute tubular necrosis. West. J. Med. 133,163-170.

32. Obermüller, N., Bernstein, P. L., Velazquez, H., Reilly, R., Moser, D., Ellison, D. H., and Bachmann, S. (1995). Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am. J. Physiol. 269, F900-F910.

33. Oimomi, M., Takase, S., and Saeki, S. (1990). Combination diuretic therapy for severe refractory nephrotic syndrome. Lancet 336, 1004-1005.

34. Okusa, M. D., Persson, A. E. G„ and Wright, F. S. (1989). Chlorothiazide effect on feedback mediated control of glomerular filtration rate. Am. J. Physiol. 257, F137-F144.

35. OsterJ. R., Epstein, M., andSmoler, S. (1983). Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann. Intern. Med. 99, 405-406.

36. Rudy, D. W., Voelker, J. R„ Greene, P. K., Esparza, F. A., and Brater, D. C. (1991). Loop diuretics for chronic renal insufficiency: A continuous infusion is more efficacious than bolus therapy. Ann. Intern. Med. 115, 360-366.

37. Ryback, L. P. (1993). Ototoxicity of loop diuretics. Ontolaryng. Clin. North Am. 26, 829-844.

38. Scherzer, P., Wald, H., and Popovtzer, M. M. (1987). Enhanced glomerular filtration and Na+ -K+ -ATPase with furosemide administration. Am. J. Physiol. 252, F910-F915.

39. Schmieder, R. E., Messerli, F. H., Decarvalho, J. G. R., and Husserl, F. E. (1987). Immediate hemodynamic response to furosemide in patients undergoing chronic hemodialysis. Am. J. Kidney Dis. 9, 55-59.

40. Shimon, 1., Almog, S., Vered, Z., Seligmann, H., Shefi, M., Peleg, E., Rosenthal, T., Motro, M., Halkin, H., and Ezra, D. (1995). Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am. J. Med. 98, 485-490.

41. Van Meyel, J. J. M., Smits, P., Dormans, T., Gerlag, P. G. G., Rüssel, F. G. M., and Gribnau, F. W.J. (1994). Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J. Intern. Med. 235, 329-334.

42. Van Vliet, A. A„ Donker, A.J. M., Nauta,J.J. P., and Verheugt, F. W. A. (1993). Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am.J. Cardiol. 71, 21A-28A.

43. Weber, K. T., and Villarreal, D. (1993). Role of aldosterone in congestive heart failure. Postgrad. Med. 93, 203-221.

44. Weber, K. T., and Villarreal, D. (1993). Aldosterone and antialdosterone therapy in congestive heart failure. Am.J. Cardiol. 71,3A-11A.

45. Zannad, F. (1993). Agiotensin-converting enzyme inhibitor and spironolactone combination therapy: New objectives in congestive heart failure treatment. Am.J. Cardiol. 71, 34A-39A.


Circulatory Support, Dopamine, and Dopamine Agonists as Adjuncts to Diuretic Therapy

David H. Ellison

West Haven VA Center for the Study and Treatment of Kidney Disease; Yale University School of Medicine, New Haven, Connecticut 06520; West Haven VA Medical Center, West Haven, Connecticut 06516

Was this article helpful?

0 0
Weight Loss Enigma

Weight Loss Enigma

Finally Revealed The Revolutionary & Miraculous Weight Loss Secrets! Discover How to Command Those Unwanted Pounds To Take A Hike, So That You Can Get Into Shape & Lose Weight Easily Just Like You Dream Of In Just A Matter Of Weeks! You're About to Discover The Insider's Fat Burning Diet Tips to Easily Shed Off Those Extra Pounds And Obtain a Lovable Shape In No Time Flat!

Get My Free Ebook

Post a comment